SPDR S&P PHARMA ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
3 Pharmaceutical ETFs That Could Be Due For A Rebound
Article By: Benzinga
Thursday, April 15, 2021 7:43 PM EDT
Here are three pharmaceutical ETFs have dropped to support, which means they may be about to rebound.
In this article: XPH, POTX, PILL
Read
Large Cap Biopharma Stalled With Move To Small Caps And Reflation Trade
Article By: Rod Raynovich
Monday, February 15, 2021 7:29 PM EDT
Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains.
In this article: LLY, XPH Also: BMY, JNJ, MRK, VRTX, IWM, XBI, XLF
Read
Pharma ETFs In Focus Post Q4 Earnings
Article By: Sweta Killa
Friday, February 5, 2021 2:48 PM EDT
The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, LLY, MRK, PFE
Read
A Low-Cost Pharma Fund For Drug Sector Exposure
Article By: MoneyShow.com
Saturday, August 22, 2020 6:59 PM EDT
The SPDR S&P Pharmaceuticals ETF (XPH) tracks an equal-weighted index of U.S. pharmaceutical companies. The exchange-traded fund seeks to provide exposure to the pharmaceuticals segment of the S&P TMI.
In this article: XPH Also: MRK, PFE, JAZZ, ZTS, CTLT, JNJ
Read
Pharma ETFs Gain On Healthy Q4 Earnings
Article By: Sweta Killa
Friday, February 7, 2020 2:14 PM EDT
Strong results led to solid trading in pharma ETFs over the past week. Here they are in detail.
In this article: IHE, PJP, PPH, XPH, FTXN
Read

Latest Tweets for $XPH

No tweets yet!

PARTNER HEADLINES